title: Radioreceptor binding profile of the atypical antipsychotic olanzapine.
abstract: The affinities of olanzapine, clozapine, haloperidol, and four potential antipsychotics were compared on binding to the neuronal receptors of a number of neurotransmitters. In both rat tissues and cell lines transfected with human receptors olanzapine had high affinity for dopamine D1, D2, D4, serotonin (5HT)2A, 5HT2C, 5HT3, alpha 1-adrenergic, histamine H1, and five muscarinic receptor subtypes. Olanzapine had lower affinity for alpha 2-adrenergic receptors and relatively low affinity for 5HT1 subtypes, GABAA, beta-adrenergic receptors, and benzodiazepine binding sites. The receptor binding affinities for olanzapine was quite similar in tissues from rat and human brain. The binding profile of olanzapine was comparable to the atypical antipsychotic clozapine, while the binding profiles for haloperidol, resperidone, remoxipride, Org 5222, and seroquel were substantially different from that of clozapine. The receptor binding profile of olanzapine is consistent with the antidopaminergic, antiserotonergic, and antimuscarinic activity observed in animal models and predicts atypical antipsychotic activity in man.
authors.affiliation: Lilly Research Laboratories, Indianapolis, IN 46285, USA.
authors.forename: F P
authors.initials: FP
authors.lastname: Bymaster
authors.forename: D O
authors.initials: DO
authors.lastname: Calligaro
authors.forename: J F
authors.initials: JF
authors.lastname: Falcone
authors.forename: R D
authors.initials: RD
authors.lastname: Marsh
authors.forename: N A
authors.initials: NA
authors.lastname: Moore
authors.forename: N C
authors.initials: NC
authors.lastname: Tye
authors.forename: P
authors.initials: P
authors.lastname: Seeman
authors.forename: D T
authors.initials: DT
authors.lastname: Wong
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000493:pharmacokinetics*; D001569:Benzodiazepines; D016466:CHO Cells; D002417:Cattle; D006224:Cricetinae; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D009206:Myocardium / Q000378:metabolism; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D011869:Radioligand Assay; D051381:Rats; D017207:Rats, Sprague-Dawley; D011941:Receptors, Adrenergic / Q000378:metabolism; D011954:Receptors, Dopamine / Q000378:metabolism; D011969:Receptors, Histamine H1 / Q000378:metabolism; D011976:Receptors, Muscarinic / Q000378:metabolism; D011985:Receptors, Serotonin / Q000378:metabolism
chemical_list: D014150:Antipsychotic Agents; D011941:Receptors, Adrenergic; D011954:Receptors, Dopamine; D011969:Receptors, Histamine H1; D011976:Receptors, Muscarinic; D011985:Receptors, Serotonin; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine